Video Experimental Relacionado
Updated: Jun 29, 2025
07:49
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
158
Desafíos y oportunidades en el desarrollo de fármacos oncológicos y en la investigación clínica en China
Feng Wang1, Dan-Yun Ruan2, Rui-Hua Xu1
1Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou 510060, P.R. China; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou 510060, P.R. China.
Cell
|March 29, 2024
Resumen
China enfrenta una carga significativa de cáncer, impulsando avances en el desarrollo de fármacos oncológicos y ensayos clínicos. Esto presenta nuevas oportunidades y desafíos para la investigación del cáncer en el país.
Área de la Ciencia:
- En el campo de la oncología
- Desarrollo de drogas
- Ensayos clínicos
Sus antecedentes:
- China, una nación muy poblada, experimenta un espectro sustancial y diverso de tipos de cáncer.
- Este paisaje epidemiológico único ofrece un entorno distinto para la investigación y el desarrollo de fármacos contra el cáncer.
Objetivo del estudio:
- Para resaltar el rápido progreso que China ha hecho en el desarrollo de fármacos oncológicos.
- Discutir las oportunidades y desafíos emergentes en el sector de la investigación sobre el cáncer en China.
Principales métodos:
- Revisión de los avances recientes en el desarrollo de medicamentos oncológicos en China.
- Análisis de las tendencias de los ensayos clínicos realizados en el país.
Principales resultados:
- Se han observado avances significativos en el desarrollo de fármacos oncológicos y en la ejecución de ensayos clínicos.
- El panorama en evolución presenta perspectivas novedosas y obstáculos complejos para el campo.
Conclusiones:
- El papel de China en la investigación oncológica global se está expandiendo.
- Conocer las oportunidades y los desafíos es crucial para el progreso futuro en el tratamiento del cáncer.
Videos de Conceptos Relacionados
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
01:28Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
01:26Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
01:21Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345